239.78
+6.31
+(2.70%)
At close: 3:29:54 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
1,566,982
1,788,279
1,738,278
822,220
Investing Cash Flow
--
-4,338,264
-2,081,724
-1,214,082
-666,933
Financing Cash Flow
--
2,804,346
228,040
-443,721
-298,731
End Cash Position
--
148,557
109,247
174,652
94,177
Capital Expenditure
--
-4,273,031
-2,072,506
-1,253,235
-768,489
Issuance of Capital Stock
--
7,734
--
--
--
Issuance of Debt
--
2,511,267
950,000
975,000
365,000
Repayment of Debt
--
-490,370
-406,224
-979,016
-508,359
Free Cash Flow
--
-2,706,049
-284,227
485,043
53,731
3/31/2021 - 1/14/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
JAGSNPHARM.NS Jagsonpal Pharmaceuticals Limited
219.84
+0.21%
GUFICBIO.NS Gufic Biosciences Limited
343.80
+0.98%
WINDLAS.NS Windlas Biotech Limited
1,067.50
-0.21%
SHILPAMED.NS Shilpa Medicare Limited
661.55
+0.90%
HIKAL.NS Hikal Limited
432.90
+4.41%
AARTIPHARM.NS Aarti Pharmalabs Limited
717.25
+0.53%
WOCKPHARMA.NS Wockhardt Limited
1,392.40
-0.71%
LAURUSLABS.NS Laurus Labs Limited
626.90
+0.28%